Beverly, United States
HepatoChem is an emerging life sciences company founded in 2008, headquartered in the United States. They are dedicated to reinventing chemistry for life sciences and focusing on biotechnology, information technology, and pharmaceutical industries. With a slogan of “Reinventing Chemistry for Life Sciences,” the company is committed to commercializing their unique approach for producing new chemical entities for metabolism study and drug discovery.
The company's last investment was a $330.00K debt financing round on 30 April 2012, in which the investor was the Massachusetts Life Sciences Center. This injection of funds will likely enable HepatoChem to continue advancing their innovative solutions in the life sciences sector.
Overall, HepatoChem’s dedication to innovation and their focus on providing unique chemical entities for drug discovery positions them as an intriguing prospect for potential investors in the life sciences and pharmaceutical sectors.
